TherapeuticsMD files lawsuit against Mayne Pharma for breach of contract over 2022 agreements

TherapeuticsMD, Inc.

Filed April 8, 2025 in U.S. District Court for Delaware (Case No. not assigned).
Seeks damages for breach of contract, implied covenant, fraudulent inducement, and unjust enrichment.
Dispute centers on net working capital allowances under License and Transaction Agreements dated December 4, 2022.
No specified damages amount; litigation outcome uncertain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.